{'fraction_non_alphanumeric': 0.0237741456166419, 'fraction_numerical': 0.005943536404160475, 'mean_word_length': 5.2407407407407405, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
COVID-19 response may lead to lasting changes in cancer care

"Many upheavals have required changes that have turned into best practices," David E Cohn, MD, MBA, chief medical officer at The Ohio State University Comprehensive Cancer Center - Arthur G James Cancer Hospital and Richard J Solove Research Institute, told HemOnc Today A 6- or 8-week delay in screening shouldn't make a difference in cancer outcome, but if patients extend the time until they get back to medical care, that definitely could change this metric The lives of oncologists have been increasingly challenged by electronic medical records, administrative structure, patient volumes and reimbursement